Applied DNA Sciences, Inc. (BNBX) — Cash Flow-to-Debt Ratio
Applied DNA Sciences, Inc. (BNBX) has a Cash Flow-to-Debt Ratio of -1.36x as of March 2026, meaning its operating cash flow of $-2.05 Million could theoretically repay -1% of its total liabilities ($1.50 Million) in one year. Explore Applied DNA Sciences, Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Applied DNA Sciences, Inc. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Applied DNA Sciences, Inc. across 5 annual periods. Also explore how large is Applied DNA Sciences, Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Applied DNA Sciences, Inc. (2021–2025)
Year-by-year debt coverage analysis for Applied DNA Sciences, Inc.. For market capitalisation and broader financial context, see Applied DNA Sciences, Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.02x | $-12.52 Million | $2.50 Million | ▼ -39.8% |
| 2024 | -3.59x | $-13.71 Million | $3.82 Million | ▼ -406.7% |
| 2023 | -0.71x | $-6.22 Million | $8.78 Million | ▲ +26.2% |
| 2022 | -0.96x | $-8.98 Million | $9.36 Million | ▲ +76.3% |
| 2021 | -4.05x | $-13.39 Million | $3.30 Million | — |